Literature DB >> 23161080

CD133 Expression Strongly Correlates with the Phenotype of Very Small Embryonic-/Epiblast-Like Stem Cells.

Mariusz Z Ratajczak1, Kasia Mierzejewska, Janina Ratajczak, Magda Kucia.   

Abstract

CD133 antigen (prominin-1) is a useful cell surface marker of very small embryonic-like stem cells (VSELs). Antibodies against it, conjugated to paramagnetic beads or fluorochromes, are thus powerful biological tools for their isolation from human umbilical cord blood, mobilized peripheral blood, and bone marrow. VSELs are described with the following characteristics: (1) are slightly smaller than red blood cells; (2) display a distinct morphology, typified by a high nuclear/cytoplasmic ratio and an unorganized euchromatin; (3) become mobilized during stress situations into peripheral blood; (4) are enriched in the CD133(+)Lin(-)CD45(-) cell fraction in humans; and (5) express markers of pluripotent stem cells (e.g., Oct-4, Nanog, and stage-specific embryonic antigen-4). The most recent in vivo data from our and other laboratories demonstrated that human VSELs exhibit some characteristics of long-term repopulating hematopoietic stem cells and are at the top of the hierarchy in the mesenchymal lineage. However, still more labor is needed to characterize better at a molecular level these rare cells.

Entities:  

Mesh:

Year:  2013        PMID: 23161080      PMCID: PMC5565199          DOI: 10.1007/978-1-4614-5894-4_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  64 in total

1.  A call to standardize teratoma assays used to define human pluripotent cell lines.

Authors:  Franz-Josef Müller; Johanna Goldmann; Peter Löser; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

Review 2.  Hunt for pluripotent stem cell -- regenerative medicine search for almighty cell.

Authors:  Mariusz Z Ratajczak; Ewa K Zuba-Surma; Marcin Wysoczynski; Wu Wan; Janina Ratajczak; Wojciech Wojakowski; Magda Kucia
Journal:  J Autoimmun       Date:  2008-02-04       Impact factor: 7.094

3.  Overview of very small embryonic-like stem cells (VSELs) and methodology of their identification and isolation by flow cytometric methods.

Authors:  Ewa K Zuba-Surma; Mariusz Z Ratajczak
Journal:  Curr Protoc Cytom       Date:  2010-01

4.  Cardiomyocyte differentiation of bone marrow-derived Oct-4+CXCR4+SSEA-1+ very small embryonic-like stem cells.

Authors:  Wojciech Wojakowski; Michal Tendera; Magda Kucia; Ewa Zuba-Surma; Krzysztof Milewski; David Wallace-Bradley; Maciej Kazmierski; Pawel Buszman; Eugeniusz Hrycek; Wieslaw Cybulski; Grzegorz Kaluza; Piotr Wieczorek; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Int J Oncol       Date:  2010-08       Impact factor: 5.650

5.  Newer insights into premeiotic development of germ cells in adult human testis using Oct-4 as a stem cell marker.

Authors:  Deepa Bhartiya; Sandhya Kasiviswanathan; Sreepoorna K Unni; Prasad Pethe; Jayesh V Dhabalia; Sujata Patwardhan; Hemant B Tongaonkar
Journal:  J Histochem Cytochem       Date:  2010-08-30       Impact factor: 2.479

Review 6.  Stem cells in aged mammalian ovaries.

Authors:  Irma Virant-Klun; Thomas Skutella
Journal:  Aging (Albany NY)       Date:  2010-01-26       Impact factor: 5.682

7.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

8.  Human cord blood-derived cells attain neuronal and glial features in vitro.

Authors:  L Buzańska; E K Machaj; B Zabłocka; Z Pojda; K Domańska-Janik
Journal:  J Cell Sci       Date:  2002-05-15       Impact factor: 5.285

9.  Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells.

Authors:  J Ratajczak; E Zuba-Surma; I Klich; R Liu; M Wysoczynski; N Greco; M Kucia; M J Laughlin; M Z Ratajczak
Journal:  Leukemia       Date:  2011-04-12       Impact factor: 11.528

10.  Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells.

Authors:  D M Shin; E K Zuba-Surma; W Wu; J Ratajczak; M Wysoczynski; M Z Ratajczak; M Kucia
Journal:  Leukemia       Date:  2009-07-30       Impact factor: 11.528

View more
  4 in total

Review 1.  The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues.

Authors:  Malwina Suszynska; Ewa K Zuba-Surma; Magdalena Maj; Kasia Mierzejewska; Janina Ratajczak; Magda Kucia; Mariusz Z Ratajczak
Journal:  Stem Cells Dev       Date:  2014-01-11       Impact factor: 3.272

2.  Molecular and phenotypic characterization of CD133 and SSEA4 enriched very small embryonic-like stem cells in human cord blood.

Authors:  A Shaikh; P Nagvenkar; P Pethe; I Hinduja; D Bhartiya
Journal:  Leukemia       Date:  2015-04-17       Impact factor: 11.528

3.  HIF-2α and Oct4 have synergistic effects on survival and myocardial repair of very small embryonic-like mesenchymal stem cells in infarcted hearts.

Authors:  Shaoheng Zhang; Lan Zhao; Jiahong Wang; Nannan Chen; Jian Yan; Xin Pan
Journal:  Cell Death Dis       Date:  2017-01-12       Impact factor: 8.469

4.  Similar Population of CD133+ and DDX4+ VSEL-Like Stem Cells Sorted from Human Embryonic Stem Cell, Ovarian, and Ovarian Cancer Ascites Cell Cultures: The Real Embryonic Stem Cells?

Authors:  Irma Virant-Klun; Petra Skerl; Srdjan Novakovic; Eda Vrtacnik-Bokal; Spela Smrkolj
Journal:  Cells       Date:  2019-07-11       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.